ID   S12A6_HUMAN             Reviewed;        1150 AA.
AC   Q9UHW9; A0AV76; Q2VI00; Q7Z2E7; Q7Z4G5; Q8TDD4; Q9UFR2; Q9Y642;
AC   Q9Y665;
DT   13-DEC-2002, integrated into UniProtKB/Swiss-Prot.
DT   13-DEC-2002, sequence version 2.
DT   10-MAY-2017, entry version 165.
DE   RecName: Full=Solute carrier family 12 member 6;
DE   AltName: Full=Electroneutral potassium-chloride cotransporter 3;
DE   AltName: Full=K-Cl cotransporter 3;
GN   Name=SLC12A6; Synonyms=KCC3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TOPOLOGY.
RC   TISSUE=Placenta;
RX   PubMed=10600773;
RA   Race J.E., Makhlouf F.N., Logue P.J., Wilson F.H., Dunham P.B.,
RA   Holtzman E.J.;
RT   "Molecular cloning and functional characterization of KCC3, a new K-Cl
RT   cotransporter.";
RL   Am. J. Physiol. 277:C1210-C1219(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), GLYCOSYLATION, AND REGULATION
RP   BY VEGF AND TNF.
RC   TISSUE=Umbilical vein;
RX   PubMed=10187864; DOI=10.1074/jbc.274.15.10661;
RA   Hiki K., D'Andrea R.J., Furze J., Crawford J., Woollatt E.,
RA   Sutherland G.R., Vadas M.A., Gamble J.R.;
RT   "Cloning, characterization, and chromosomal location of a novel human
RT   K+-Cl- cotransporter.";
RL   J. Biol. Chem. 274:10661-10667(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=10347194; DOI=10.1074/jbc.274.23.16355;
RA   Mount D.B., Mercado A., Song L., Xu J., George A.L. Jr., Delpire E.,
RA   Gamba G.;
RT   "Cloning and characterization of KCC3 and KCC4, new members of the
RT   cation-chloride cotransporter gene family.";
RL   J. Biol. Chem. 274:16355-16362(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], ALTERNATIVE SPLICING (ISOFORMS 1
RP   AND 2), GLYCOSYLATION, AND DISEASE.
RX   PubMed=12368912; DOI=10.1038/ng1002;
RA   Howard H.C., Mount D.B., Rochefort D., Byun N., Dupre N., Lu J.,
RA   Fan X., Song L., Riviere J.-B., Prevost C., Horst J., Simonati A.,
RA   Lemcke B., Welch R., England R., Zhan F.Q., Mercado A., Siesser W.B.,
RA   George A.L. Jr., McDonald M.P., Bouchard J.-P., Mathieu J.,
RA   Delpire E., Rouleau G.A.;
RT   "The K-Cl cotransporter KCC3 is mutant in a severe peripheral
RT   neuropathy associated with agenesis of the corpus callosum.";
RL   Nat. Genet. 32:384-392(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3; 4; 5), ALTERNATIVE SPLICING
RP   (ISOFORM 6), ALTERNATIVE PROMOTER USAGE, TISSUE SPECIFICITY, AND
RP   BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16048901; DOI=10.1152/ajprenal.00464.2004;
RA   Mercado A., Vazquez N., Song L., Cortes R., Enck A.H., Welch R.,
RA   Delpire E., Gamba G., Mount D.B.;
RT   "NH2-terminal heterogeneity in the KCC3 K+-Cl- cotransporter.";
RL   Am. J. Physiol. 289:F1246-1261(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 70-1150 (ISOFORM 1).
RC   TISSUE=Testis;
RA   Guo J.H., Yu L.;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 137-1150 (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [12]
RP   SUBUNIT.
RX   PubMed=11551954; DOI=10.1074/jbc.M107155200;
RA   Casula S., Shmukler B.E., Wilhelm S., Stuart-Tilley A.K., Su W.,
RA   Chernova M.N., Brugnara C., Alper S.L.;
RT   "A dominant negative mutant of the KCC1 K-Cl cotransporter: both N-
RT   and C-terminal cytoplasmic domains are required for K-Cl cotransport
RT   activity.";
RL   J. Biol. Chem. 276:41870-41878(2001).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1032, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   ENZYME REGULATION.
RX   PubMed=21613606; DOI=10.1152/ajpcell.00070.2011;
RA   Cruz-Rangel S., Melo Z., Vazquez N., Meade P., Bobadilla N.A.,
RA   Pasantes-Morales H., Gamba G., Mercado A.;
RT   "Similar Effects of all WNK3 Variants upon SLC12 Cotransporters.";
RL   Am. J. Physiol. 301:C601-C608(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1032, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-120; SER-148 AND
RP   SER-1032, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Mediates electroneutral potassium-chloride cotransport.
CC       May be activated by cell swelling. May contribute to cell volume
CC       homeostasis in single cells.
CC   -!- ENZYME REGULATION: Activated by N-ethylmaleimide (NEM). Inhibited
CC       by DIOA, bumetanide and furosemide. Inhibited by WNK3.
CC       {ECO:0000269|PubMed:21613606}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.7 mM for extracellular Rb(+) (isoform 1)
CC         {ECO:0000269|PubMed:16048901};
CC         KM=7.3 mM for extracellular Cl(-) (isoform 1)
CC         {ECO:0000269|PubMed:16048901};
CC         KM=17.2 mM for extracellular Rb(+) (isoform 2)
CC         {ECO:0000269|PubMed:16048901};
CC         KM=8.2 mM for extracellular Cl(-) (isoform 2)
CC         {ECO:0000269|PubMed:16048901};
CC   -!- SUBUNIT: Homomultimer and heteromultimer with other K-Cl
CC       cotransporters. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane {ECO:0000250};
CC       Multi-pass membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=6;
CC       Name=1; Synonyms=KCC3a;
CC         IsoId=Q9UHW9-1; Sequence=Displayed;
CC       Name=2; Synonyms=KCC3b;
CC         IsoId=Q9UHW9-2; Sequence=VSP_006115, VSP_006116;
CC         Note=Produced by alternative promoter usage.;
CC       Name=3; Synonyms=KCC3a-X2M;
CC         IsoId=Q9UHW9-3; Sequence=VSP_041389;
CC         Note=Does not differ in the osmotic set point of swelling
CC         activation but, activation is more rapid.;
CC       Name=4; Synonyms=KCC3a-S3;
CC         IsoId=Q9UHW9-4; Sequence=VSP_041388;
CC       Name=5; Synonyms=KCC3a-S, KCC3a-S1, KCC3a-S2;
CC         IsoId=Q9UHW9-5; Sequence=VSP_041387;
CC         Note=Does not differ in the osmotic set point of swelling
CC         activation but, activation is more rapid.;
CC       Name=6; Synonyms=KCC3b-X2M;
CC         IsoId=Q9UHW9-6; Sequence=VSP_006115, VSP_006116, VSP_041389;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart, brain and kidney.
CC       Detected at lower levels in skeletal muscle, placenta, lung and
CC       pancreas. Detected in umbilical vein endothelial cells. Isoform 2
CC       is more abundant in kidney. Isoform 5 is testis specific.
CC       Expressed in the proximal tubule of the kidney (at protein level).
CC       {ECO:0000269|PubMed:16048901}.
CC   -!- INDUCTION: Up-regulated by VEGF. Down-regulated by TNF.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:10187864,
CC       ECO:0000269|PubMed:12368912}.
CC   -!- DISEASE: Agenesis of the corpus callosum, with peripheral
CC       neuropathy (ACCPN) [MIM:218000]: A disease that is characterized
CC       by severe progressive sensorimotor neuropathy, mental retardation,
CC       dysmorphic features and complete or partial agenesis of the corpus
CC       callosum. Note=The disease is caused by mutations affecting the
CC       gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the SLC12A transporter family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF116242; AAF24986.1; -; mRNA.
DR   EMBL; AF108831; AAD25337.1; -; mRNA.
DR   EMBL; AF105366; AAD39742.1; -; mRNA.
DR   EMBL; AF314956; AAM96215.1; -; Genomic_DNA.
DR   EMBL; AF314931; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314933; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314934; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314935; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314936; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314937; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314938; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314939; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314940; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314941; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314942; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314943; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314944; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314945; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314946; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314947; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314948; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314949; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314950; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314951; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314952; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314953; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314954; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314955; AAM96215.1; JOINED; Genomic_DNA.
DR   EMBL; AF314956; AAM96216.1; -; Genomic_DNA.
DR   EMBL; AF314932; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314933; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314934; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314935; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314936; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314937; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314938; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314939; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314940; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314941; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314942; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314943; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314944; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314945; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314946; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314947; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314948; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314949; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314950; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314951; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314952; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314953; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314954; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF314955; AAM96216.1; JOINED; Genomic_DNA.
DR   EMBL; AF531258; AAQ10026.1; -; mRNA.
DR   EMBL; AF531259; AAQ10027.1; -; mRNA.
DR   EMBL; AF531260; AAQ10028.1; -; mRNA.
DR   EMBL; DQ138323; ABA02873.1; -; mRNA.
DR   EMBL; AK315283; BAG37692.1; -; mRNA.
DR   EMBL; AC021822; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079203; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471125; EAW92295.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92297.1; -; Genomic_DNA.
DR   EMBL; CH471125; EAW92301.1; -; Genomic_DNA.
DR   EMBL; BC126241; AAI26242.1; -; mRNA.
DR   EMBL; BC126243; AAI26244.1; -; mRNA.
DR   EMBL; AF477977; AAL85335.1; -; mRNA.
DR   EMBL; AL117500; CAB55965.1; -; mRNA.
DR   CCDS; CCDS10036.1; -. [Q9UHW9-2]
DR   CCDS; CCDS42010.1; -. [Q9UHW9-3]
DR   CCDS; CCDS42011.1; -. [Q9UHW9-4]
DR   CCDS; CCDS42012.1; -. [Q9UHW9-5]
DR   CCDS; CCDS58352.1; -. [Q9UHW9-1]
DR   PIR; T17275; T17275.
DR   RefSeq; NP_001035959.1; NM_001042494.1. [Q9UHW9-5]
DR   RefSeq; NP_001035960.1; NM_001042495.1. [Q9UHW9-5]
DR   RefSeq; NP_001035961.1; NM_001042496.1. [Q9UHW9-4]
DR   RefSeq; NP_001035962.1; NM_001042497.1. [Q9UHW9-3]
DR   RefSeq; NP_005126.1; NM_005135.2. [Q9UHW9-2]
DR   RefSeq; NP_598408.1; NM_133647.1. [Q9UHW9-1]
DR   UniGene; Hs.510939; -.
DR   ProteinModelPortal; Q9UHW9; -.
DR   BioGrid; 115311; 14.
DR   IntAct; Q9UHW9; 4.
DR   STRING; 9606.ENSP00000452776; -.
DR   DrugBank; DB00761; Potassium Chloride.
DR   TCDB; 2.A.30.5.3; the cation-chloride cotransporter (ccc) family.
DR   iPTMnet; Q9UHW9; -.
DR   PhosphoSitePlus; Q9UHW9; -.
DR   BioMuta; SLC12A6; -.
DR   DMDM; 27151690; -.
DR   EPD; Q9UHW9; -.
DR   PaxDb; Q9UHW9; -.
DR   PeptideAtlas; Q9UHW9; -.
DR   PRIDE; Q9UHW9; -.
DR   Ensembl; ENST00000290209; ENSP00000290209; ENSG00000140199. [Q9UHW9-2]
DR   Ensembl; ENST00000354181; ENSP00000346112; ENSG00000140199. [Q9UHW9-1]
DR   Ensembl; ENST00000397702; ENSP00000380814; ENSG00000140199. [Q9UHW9-5]
DR   Ensembl; ENST00000397707; ENSP00000380819; ENSG00000140199. [Q9UHW9-3]
DR   Ensembl; ENST00000458406; ENSP00000387725; ENSG00000140199. [Q9UHW9-5]
DR   Ensembl; ENST00000558589; ENSP00000452776; ENSG00000140199. [Q9UHW9-4]
DR   Ensembl; ENST00000558667; ENSP00000453473; ENSG00000140199. [Q9UHW9-1]
DR   Ensembl; ENST00000560611; ENSP00000454168; ENSG00000140199. [Q9UHW9-1]
DR   GeneID; 9990; -.
DR   KEGG; hsa:9990; -.
DR   UCSC; uc001zhv.4; human. [Q9UHW9-1]
DR   CTD; 9990; -.
DR   DisGeNET; 9990; -.
DR   GeneCards; SLC12A6; -.
DR   GeneReviews; SLC12A6; -.
DR   HGNC; HGNC:10914; SLC12A6.
DR   HPA; HPA034563; -.
DR   MalaCards; SLC12A6; -.
DR   MIM; 218000; phenotype.
DR   MIM; 604878; gene.
DR   neXtProt; NX_Q9UHW9; -.
DR   OpenTargets; ENSG00000140199; -.
DR   Orphanet; 1496; Corpus callosum agenesis - neuronopathy.
DR   PharmGKB; PA35808; -.
DR   eggNOG; KOG2082; Eukaryota.
DR   eggNOG; COG0531; LUCA.
DR   GeneTree; ENSGT00760000119053; -.
DR   HOGENOM; HOG000092644; -.
DR   HOVERGEN; HBG052852; -.
DR   InParanoid; Q9UHW9; -.
DR   KO; K14427; -.
DR   OMA; DRTSHPQ; -.
DR   OrthoDB; EOG091G0WB4; -.
DR   PhylomeDB; Q9UHW9; -.
DR   TreeFam; TF313657; -.
DR   Reactome; R-HSA-426117; Cation-coupled Chloride cotransporters.
DR   SIGNOR; Q9UHW9; -.
DR   ChiTaRS; SLC12A6; human.
DR   GeneWiki; SLC12A6; -.
DR   GenomeRNAi; 9990; -.
DR   PRO; PR:Q9UHW9; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000140199; -.
DR   CleanEx; HS_SLC12A6; -.
DR   ExpressionAtlas; Q9UHW9; baseline and differential.
DR   Genevisible; Q9UHW9; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0022820; F:potassium ion symporter activity; IBA:GO_Central.
DR   GO; GO:0015079; F:potassium ion transmembrane transporter activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0015379; F:potassium:chloride symporter activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0035827; F:rubidium ion transmembrane transporter activity; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0001525; P:angiogenesis; NAS:UniProtKB.
DR   GO; GO:0071476; P:cellular hypotonic response; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0071477; P:cellular hypotonic salinity response; IDA:UniProtKB.
DR   GO; GO:0007268; P:chemical synaptic transmission; IBA:GO_Central.
DR   GO; GO:0006811; P:ion transport; IDA:UniProtKB.
DR   GO; GO:0010107; P:potassium ion import; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0035826; P:rubidium ion transport; IMP:ParkinsonsUK-UCL.
DR   InterPro; IPR004841; AA-permease/SLC12A_dom.
DR   InterPro; IPR030364; KCC3.
DR   InterPro; IPR000076; KCL_cotranspt.
DR   InterPro; IPR018491; SLC12_C.
DR   InterPro; IPR004842; SLC12A_fam.
DR   PANTHER; PTHR11827:SF77; PTHR11827:SF77; 1.
DR   Pfam; PF00324; AA_permease; 2.
DR   Pfam; PF03522; SLC12; 2.
DR   PRINTS; PR01081; KCLTRNSPORT.
DR   TIGRFAMs; TIGR00930; 2a30; 1.
PE   1: Evidence at protein level;
KW   Alternative promoter usage; Alternative splicing; Cell membrane;
KW   Complete proteome; Glycoprotein; Ion transport; Membrane; Neuropathy;
KW   Phosphoprotein; Polymorphism; Potassium; Potassium transport;
KW   Reference proteome; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN         1   1150       Solute carrier family 12 member 6.
FT                                /FTId=PRO_0000178037.
FT   TOPO_DOM      1    185       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    186    208       Helical. {ECO:0000255}.
FT   TOPO_DOM    209    223       Extracellular. {ECO:0000255}.
FT   TRANSMEM    224    245       Helical. {ECO:0000255}.
FT   TOPO_DOM    246    271       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    272    295       Helical. {ECO:0000255}.
FT   TOPO_DOM    296    318       Extracellular. {ECO:0000255}.
FT   TRANSMEM    319    343       Helical. {ECO:0000255}.
FT   TOPO_DOM    344    346       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    347    371       Helical. {ECO:0000255}.
FT   TOPO_DOM    372    479       Extracellular. {ECO:0000255}.
FT   TRANSMEM    480    501       Helical. {ECO:0000255}.
FT   TOPO_DOM    502    515       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    516    543       Helical. {ECO:0000255}.
FT   TOPO_DOM    544    557       Extracellular. {ECO:0000255}.
FT   TRANSMEM    558    581       Helical. {ECO:0000255}.
FT   TOPO_DOM    582    620       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    621    644       Helical. {ECO:0000255}.
FT   TOPO_DOM    645    647       Extracellular. {ECO:0000255}.
FT   TRANSMEM    648    670       Helical. {ECO:0000255}.
FT   TOPO_DOM    671    676       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    677    695       Helical. {ECO:0000255}.
FT   TOPO_DOM    696    696       Extracellular. {ECO:0000255}.
FT   TRANSMEM    697    719       Helical. {ECO:0000255}.
FT   TOPO_DOM    720   1150       Cytoplasmic. {ECO:0000255}.
FT   COMPBIAS    227    230       Poly-Cys.
FT   MOD_RES      32     32       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     120    120       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     148    148       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES    1032   1032       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    379    379       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    398    398       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    411    411       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    428    428       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1     59       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:16048901}.
FT                                /FTId=VSP_041387.
FT   VAR_SEQ       1     51       Missing (in isoform 2 and isoform 6).
FT                                {ECO:0000303|PubMed:10187864,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006115.
FT   VAR_SEQ       1      9       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:16048901}.
FT                                /FTId=VSP_041388.
FT   VAR_SEQ      52     90       PETSRSEPMSEMSGATTSLATVALDPPSDRTSHPQDVIE
FT                                -> MPHFTVTKVEDPEEGAAASISQEPSLADIKARIQDSDE
FT                                P (in isoform 2 and isoform 6).
FT                                {ECO:0000303|PubMed:10187864,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_006116.
FT   VAR_SEQ      91    105       Missing (in isoform 3 and isoform 6).
FT                                {ECO:0000303|PubMed:16048901}.
FT                                /FTId=VSP_041389.
FT   VARIANT     415    415       F -> S (in dbSNP:rs2705339).
FT                                /FTId=VAR_014960.
FT   CONFLICT    802    802       E -> H (in Ref. 1; AAF24986).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1150 AA;  127617 MW;  F8BDD39181294EDD CRC64;
     MHPPETTTKM ASVRFMVTPT KIDDIPGLSD TSPDLSSRSS SRVRFSSRES VPETSRSEPM
     SEMSGATTSL ATVALDPPSD RTSHPQDVIE DLSQNSITGE HSQLLDDGHK KARNAYLNNS
     NYEEGDEYFD KNLALFEEEM DTRPKVSSLL NRMANYTNLT QGAKEHEEAE NITEGKKKPT
     KTPQMGTFMG VYLPCLQNIF GVILFLRLTW VVGTAGVLQA FAIVLICCCC TMLTAISMSA
     IATNGVVPAG GSYFMISRAL GPEFGGAVGL CFYLGTTFAA AMYILGAIEI FLVYIVPRAA
     IFHSDDALKE SAAMLNNMRV YGTAFLVLMV LVVFIGVRYV NKFASLFLAC VIVSILAIYA
     GAIKSSFAPP HFPVCMLGNR TLSSRHIDVC SKTKEINNMT VPSKLWGFFC NSSQFFNATC
     DEYFVHNNVT SIQGIPGLAS GIITENLWSN YLPKGEIIEK PSAKSSDVLG SLNHEYVLVD
     ITTSFTLLVG IFFPSVTGIM AGSNRSGDLK DAQKSIPIGT ILAILTTSFV YLSNVVLFGA
     CIEGVVLRDK FGDAVKGNLV VGTLSWPSPW VIVIGSFFST CGAGLQSLTG APRLLQAIAK
     DNIIPFLRVF GHSKANGEPT WALLLTAAIA ELGILIASLD LVAPILSMFF LMCYLFVNLA
     CALQTLLRTP NWRPRFRYYH WALSFMGMSI CLALMFISSW YYAIVAMVIA GMIYKYIEYQ
     GAEKEWGDGI RGLSLSAARF ALLRLEEGPP HTKNWRPQLL VLLKLDEDLH VKHPRLLTFA
     SQLKAGKGLT IVGSVIVGNF LENYGEALAA EQTIKHLMEA EKVKGFCQLV VAAKLREGIS
     HLIQSCGLGG MKHNTVVMGW PNGWRQSEDA RAWKTFIGTV RVTTAAHLAL LVAKNISFFP
     SNVEQFSEGN IDVWWIVHDG GMLMLLPFLL KQHKVWRKCS IRIFTVAQLE DNSIQMKKDL
     ATFLYHLRIE AEVEVVEMHD SDISAYTYER TLMMEQRSQM LRHMRLSKTE RDREAQLVKD
     RNSMLRLTSI GSDEDEETET YQEKVHMTWT KDKYMASRGQ KAKSMEGFQD LLNMRPDQSN
     VRRMHTAVKL NEVIVNKSHE AKLVLLNMPG PPRNPEGDEN YMEFLEVLTE GLERVLLVRG
     GGSEVITIYS
//
